Quadrant Capital Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-349
| Closed | -$1.22K | – | 2756 |
|
|
2024
Q3 | $1.22K | Buy |
349
+81
| +30% | +$284 | ﹤0.01% | 2564 |
|
|
2024
Q2 | $880 | Sell |
268
-172
| -39% | -$565 | ﹤0.01% | 2576 |
|
|
2024
Q1 | $3.23K | Buy |
+440
| New | +$3.23K | ﹤0.01% | 2410 |
|
|
2023
Q3 | – | Sell |
-417
| Closed | -$1.99K | – | 2713 |
|
|
2023
Q2 | $1.99K | Sell |
417
-3,278
| -89% | -$15.6K | ﹤0.01% | 2417 |
|
|
2023
Q1 | $21.1K | Buy |
3,695
+2,956
| +400% | +$16.9K | ﹤0.01% | 1677 |
|
|
2022
Q4 | $7.46K | Buy |
739
+722
| +4,247% | +$7.29K | ﹤0.01% | 2084 |
|
|
2022
Q3 | $0 | Sell |
17
-17
| -50% | – | ﹤0.01% | 2690 |
|
|
2022
Q2 | $1K | Sell |
34
-196
| -85% | -$5.77K | ﹤0.01% | 2359 |
|
|
2022
Q1 | $9K | Buy |
230
+190
| +475% | +$7.44K | ﹤0.01% | 1690 |
|
|
2021
Q4 | $2K | Buy |
40
+33
| +471% | +$1.65K | ﹤0.01% | 2124 |
|
|
2021
Q3 | $0 | Buy |
7
+1
| +17% | – | ﹤0.01% | 2539 |
|
|
2021
Q2 | $1K | Sell |
6
-2
| -25% | -$333 | ﹤0.01% | 2254 |
|
|
2021
Q1 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 2209 |
|